Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program

Donation marks a new phase for Blood Cancer United's venture philanthropy program, with returns reinvested to support future therapies NEW YORK, NY and WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Blood Cancer United and Royalty Pharma today announced a $7.5 million donation from Royalty...